Capital Advisory Group Advisory Services, LLC Axogen, Inc. Transaction History

Capital Advisory Group Advisory Services, LLC

$250 Million
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$6.99 - $10.0 $699 - $1,000	-100 Closed	0 $0
Q1 2022 Apr 29, 2022	BUY	$7.26 - $10.7 $726 - $1,070	100 New	100 $1,000
Q4 2021 Feb 15, 2022	SELL	$8.8 - $16.0 $880 - $1,600	-100 Closed	0 $0
Q4 2020 Feb 18, 2021	BUY	$11.5 - $17.96 $1,150 - $1,796	100 New	100 $2,000

Others Institutions Holding AXGN

# of Institutions

162

Shares Held

36.6M

Call Options Held

230K

Put Options Held

400

First Light Asset Management, LLC Edina, MN

4.09M
Shares

$64 Million
5.0% of portfolio
Black Rock Inc. New York, NY

3.25M
Shares

$50.8 Million
0.0% of portfolio
Soleus Capital Management, L.P. Greenwich, CT

3.01M
Shares

$47 Million
3.58% of portfolio
Morgan Stanley New York, NY

2.9M
Shares

$45.4 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

2.43M
Shares

$37.9 Million
0.0% of portfolio

View Full List

About Axogen, Inc.

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $661M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

More about AXGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Advisory Group Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Advisory Group Advisory Services, LLC with notifications on news.

Account